Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.

BACKGROUND High-resolution computed tomography (HRCT) of lung adenocarcinoma at early stage shows pure ground-glass opacity (GGO) and most cases of pure GGO remain stable during follow-up. There is no consensus on the strategy for follow-up. Identification of the molecular mechanisms that are associated with the natural history of lung adenocarcinoma should provide useful information. METHODS Twenty-three lung adenocarcinomas that were followed-up for more than 6 months pre-operatively by HRCT were included in this study. Patterns of radiological changes during the follow-up period were classified into three groups; type 1, pure GGO without consolidation; type 2, appearance or increase in consolidation within pure GGO; type 3, consolidation without pure GGO. Mutational analysis of the epidermal growth factor receptor (EGFR) and K-ras genes and immunohistochemical staining of p53 protein were performed. RESULTS EGFR mutations were found in 17 cases (74%), and there was no K-ras mutation. Positive staining of p53 was found in 8 cases (35%). As for radiological findings during the follow-up period, the frequencies of EGFR mutations and positive p53 staining were 67 and 0% in type 1 (n = 9), 89 and 44% in type 2 (n = 9) and 60 and 80% in type 3 (n = 5). CONCLUSIONS EGFR mutations were frequently found in lung adenocarcinoma with GGO on HRCT in this study. Inactivation of p53 may be associated with the appearance of central consolidation within pure GGO on HRCT which reflects invasive features and may be useful as a molecular marker during the follow-up of pure GGO.

[1]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[2]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[3]  J. Austin,et al.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. , 2005, Radiology.

[4]  M. L. R. D. Christenson.  Mucin-Producing Adenocarcinoma of the Lung: Thin-Section Computed Tomography Findings in 48 Patients and Their Effect on Prognosis , 2006 .

[5]  M. Kris,et al.  Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. , 2002, The Annals of thoracic surgery.

[6]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[7]  S. Hirohashi,et al.  Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. , 2005, Lung cancer.

[8]  T. Fabian.  Multiple primary lung cancers. , 2018, Journal of thoracic disease.

[9]  S. Kitano,et al.  Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. , 2004, The American journal of pathology.

[10]  M. L. R. D. Christenson,et al.  Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement From the Fleischner Society , 2006 .

[11]  S. Sone,et al.  CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. , 2003, AJR. American journal of roentgenology.

[12]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[13]  S. Hirohashi,et al.  Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes , 1990, Cancer.

[14]  Y. Yatabe,et al.  Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. , 1998, Journal of the National Cancer Institute.

[15]  Y. Yatabe,et al.  EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma , 2005, The American journal of surgical pathology.

[16]  T. Soussi,et al.  Serum p53 antibodies as early markers of lung cancer , 1995, Nature Medicine.

[17]  Tesshi Yamada,et al.  Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive Components: Clinicopathological Features, Subclassification by Extent of Invasive Foci, and Immunohistochemical Characterization , 2003, The American journal of surgical pathology.

[18]  M. Kusumoto,et al.  CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. , 2004, AJR. American journal of roentgenology.

[19]  Kenji Suzuki,et al.  A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. , 2003, The Annals of thoracic surgery.

[20]  H Nakata,et al.  Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. , 2000, AJR. American journal of roentgenology.

[21]  Mordecai Schwartz.  A biomathematical approach to clinical tumor growth , 1961, Cancer.

[22]  Hironobu Ohmatsu,et al.  Progression of Focal Pure Ground-Glass Opacity Detected by Low-Dose Helical Computed Tomography Screening for Lung Cancer , 2004, Journal of computer assisted tomography.

[23]  N. Müller,et al.  Mucin-Producing Adenocarcinoma of the Lung: Thin-Section Computed Tomography Findings in 48 Patients and Their Effect on Prognosis , 2005, Journal of computer assisted tomography.

[24]  Ken Kodama,et al.  Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. , 2002, The Annals of thoracic surgery.

[25]  L. Liotta,et al.  Laser capture microdissection. , 2006, Methods in molecular biology.

[26]  T. Shibata,et al.  Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  K. Eguchi,et al.  Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. , 2003, The Annals of thoracic surgery.

[28]  H. Ohmatsu,et al.  Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. , 1996, Radiology.